Pharmaceutical Drug Delivery Market Size & Share 2023 to 2032

Market Size by Route Of Administration (Oral, Injectable, Self-Injectors, Topical, Pulmonary, Nasal, Transmucosal), by Application, Facility Of Use (Hospitals, Clinics, Home Care Settings.
Report ID: GMI5565
   |
Published Date: April 2023
 | 
Report Format: PDF

Download Free PDF

Pharmaceutical Drug Delivery Market Size

Pharmaceutical Drug Delivery Market size was more than USD 1.6 trillion in 2022 and is forecast to observe more than 7% CAGR from 2023 to 2032. The rising adoption of self-administration and home care will influence the market development.
 

Pharmaceutical Drug Delivery Market

Emerging preferences for self-administration and at-home care will influence the market trends. A large portion of the elderly population is preferring home care over hospital care as it is a more affordable and practical option. The high prevalence of many diseases and an increase in the number of diabetic patients worldwide has resulted in the widespread usage of self-injector devices for the administration of insulin. As patients are choosing self-administration devices to eliminate the high costs of hospitalization and caregivers, many companies are launching new drug delivery products to meet the impending demand. For instance, in May 2022, Jabil Healthcare launched the Qfinity Autoinjector Platform which is a reusable drug delivery device.
 

 

Concerns over needlestick injuries could hamper the growth of the pharmaceutical drug delivery market. Injuries from needlesticks happen when a needle inadvertently pierces the skin. Such wounds are dangerous because they can spread bacteria that can result in deadly bloodborne diseases. As per estimates, around 600,000 to 800,000 needlestick injuries are recorded in the US each year. Healthcare workers are at high risk of needlestick injuries which can lead to serious or fatal infections.
 

Pharmaceutical Drug Delivery Market Analysis

Global Pharmaceutical Drug Delivery Market Size, By Route of Administration

Pharmaceutical drug delivery market share from the injectable segment is expected to witness a 7.4% CAGR from 2023 to 2032. There are two types of injectable drug delivery systems: traditional and self-injecting. These devices have gained popularity during the COVID-19 pandemic for making vaccines and is continued to be used to treat conditions like diabetes, cancer, and cardiovascular disease. With the rising number of chronic diseases, the demand for these products will increase worldwide. Pharmaceutical companies are actively expanding their manufacturing capacity to boost the production of injectable drug delivery products. For instance, in October 2022, Eisai launched a new injectable drug delivery facility worth USD 69 million. The company built a research building for the development of new products in the segment.
 

 

Global Pharmaceutical Drug Delivery Market Size, By Application

Pharmaceutical drug delivery market share from the infectious diseases segment is predicted to reach more than USD 555 billion by 2032. Worldwide, the prevalence of infectious diseases including SARS, swine flu, TB, and others is rising. Oral or injectable drug delivery techniques are majorly used for the effective treatment of infectious disorders. Climate change and viruses like COVID-19 are increasing the burden of healthcare infrastructure, driving the need for effective drug delivery solutions. As per the CDC, the West Nile virus, Lyme disease, and valley fever are a few examples of infectious diseases that have spread over the years.
 

 

Pharmaceutical drug delivery market share from the hospitals segment is expected to reach over USD 1.8 trillion by 2032. This growth will be accelerated by the large patient population visiting hospitals for a range of diseases. Hospitals also provide a wide range of medical services to patients, which accelerates market growth. The advanced infrastructure and medical devices present in hospitals attract more patients. The development of cutting-edge technologies and the presence of highly skilled professionals will influence market growth over the coming years.
 

 

North America Pharmaceutical Drug Delivery Market Size

North America pharmaceutical drug delivery market share was nearly 49% in 2022. Alcohol consumption, smoking, and sedentary behavior are all contributing to an increase in cases of diseases, which will support market expansion. Additionally, the region is home to a significant number of well-known pharmaceutical brands. Multiple hospitals and other healthcare facilities are in abundance in the region. Furthermore, high healthcare expenditures and expanding government initiatives to support improvement in healthcare sector is expected to endorse pharmaceutical drug delivery companies in the region.
 

Pharmaceutical Drug Delivery Market Share

  • Johnson & Johnson
  • AstraZeneca plc
  • AbbVie Inc
  • Bayer AG
  • Amgen Inc
  • Eli Lilly and Company
  • Sanofi
  • Merck & Co Inc.
  • GILEAD SCIENCES, INC.,
  • Pfizer Inc.

are some of the key players in the global pharmaceutical drug delivery market. Initiatives by the companies like partnerships, collaborations, and new product launches are expected to increase market growth over the years. For instance, in March 2023, Sanofi reduced the cost of their popular insulin Lantus by 78% with a cap of USD 35 in order to make the out-of-pocket drugs more affordable for all patients with commercial insurance.
 

The pharmaceutical drug delivery market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

By Route of Administration

  • Oral drug delivery
    • Solid oral drugs
      • Tablets
      • Capsules
      • Powders
      • Pills
    • Liquid oral drugs
      • Syrups
      • Solutions
    • Semi solid oral drugs                    
      • Gels      
      • Emulsions          
      • Elixirs    
  • Injectable drug delivery
    • Conventional injection devices                
      • By material        
        • Glass syringes
        • Plastic syringes
      • By Product        
        • Fillable syringes
        • Prefilled syringes
      • By Usability       
        • Reusable syringes
        • Disposable syringes
    • Self-injection devices
      • Needle-free injectors    
      • Autoinjectors    
      • Pen injectors     
      • Wearable injectors        
    • Other injector devices
  • Topical drug delivery                                   
    • Liquid formulations                      
      • Solutions            
      • Suspensions      
    • Semi-solid formulations                             
      • Creams
      • Gels      
      • Ointments         
      • Pastes  
      • Lotions
    • Solid formulations                        
      • Suppositories    
      • Powders             
    • Transdermal products                 
      • Transdermal patches    
      • Transdermal gels            
  • Ocular drug delivery                                    
    • Liquid formulations                      
      • Eye drops           
      • Liquid sprays     
    • Semisolid formulations               
      • Gels      
      • Eye ointments  
    • Ocular devices                 
      • Drug-coated contact lenses        
      • Ocular inserts   
  • Pulmonary drug delivery                                           
    • Metered-dose inhalers                
    • Dry powder inhalers                     
    • Nebulizers                         
      • Jet nebulizers    
      • Ultrasonic nebulizers     
      • Soft mist nebulizers       
  • Nasal drug delivery                                      
    • Nasal drops                      
    • Nasal sprays                     
    • Nasal powders                
    • Nasal gels                         
  • Transmucosal drug delivery                                     
    • Oral formulations                          
      • Buccal drug delivery      
      • Sublingual drug delivery              
    • Other transmucosal drug delivery technologies
      • Rectal drug delivery                      
      • Vaginal drug delivery                   
  • Implantable drug delivery
    • Active implantable drug delivery            
    • Passive implantable drug delivery

By Application

  • Infectious diseases
  • Cancer 
  • Cardiovascular  diseases
  • Diabetes
  • Respiratory diseases      
  • Central nervous system disorders
  • Autoimmune diseases
  • Other applications         

By Facility of Use

  • Hospitals
  • Ambulatory surgical centers and clinics
  • Home care settings
  • Diagnostic centers
  • Other facilities of use

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

 

Authors: Monali Tayade, Jignesh Rawal
Pharmaceutical Drug Delivery Market Scope
  • Pharmaceutical Drug Delivery Market Size
  • Pharmaceutical Drug Delivery Market Trends
  • Pharmaceutical Drug Delivery Market Analysis
  • Pharmaceutical Drug Delivery Market Share

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope and definitions

1.3    Base estimates and working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Pharmaceutical drug delivery industry 3600 synopsis, 2018 - 2032

2.2    Business trends

2.3    Route of administration trends

2.4    Application trends

2.5    Facility of use trends

2.6    Regional trends

Chapter 3   Pharmaceutical Drug Delivery Market Insights

3.1    Industry segmentation

3.2    Industry landscape, 2018 - 2032 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Rising prevalence of chronic diseases

3.3.1.2   Growth in the biologics market

3.3.1.3   Technological advancement and new product launches

3.3.1.4   Increasing investment in pharmaceutical R&D

3.3.1.5   Self-administration and home care

3.3.2    Industry pitfalls & challenges

3.3.2.1   Risk of needlestick injuries

.3.3.2.2.    Cost intensive drug development process

3.4    Growth potential analysis

3.4.1    By route of administration

3.4.2    By application

3.4.3    By facility of use

3.5    COVID- 19 impact analysis

3.6    Regulatory landscape

3.7    Porter's analysis

3.8    PESTLE Analysis

Chapter 4   Competitive landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Competitive positioning matrix, 2022

4.4    Company market share analysis, 2022

4.5    Strategic outlook matrix, 2022

4.6    Strategy dashboard, 2022

Chapter 5   Pharmaceutical Drug Delivery Market, By Route of Administration

5.1    Key segment trends

5.2    Oral drug delivery

5.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.2    Solid oral drugs

5.2.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.2.2.2   Tablets

5.2.2.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.2.3   Capsules

5.2.2.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.2.4   Powder

5.2.2.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.2.5   Pills

5.2.2.5.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.3    Liquid oral drugs

5.2.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.2.3.2   Syrups

5.2.3.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.3.3   Solutions

5.2.3.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.4    Semi-solid oral drugs

5.2.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.2.4.2   Gels

5.2.4.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.4.3   Emulsions

5.2.4.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.2.4.4   Elixirs

5.2.4.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.3    Injectable drug delivery

5.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2    Conventional injection devices

5.3.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.2.2   By material

5.3.2.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.2.2    Glass syringes

5.3.2.2.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.2.3    Plastic syringes

5.3.2.2.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.3   By product

5.3.2.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.3.2    Fillable syringes

5.3.2.3.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.3.3    Prefilled syringes

5.3.2.3.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.4   By usability

5.3.2.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.4.2    Reusable syringes

5.3.2.4.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.2.4.3    Disposable syringes

5.3.2.4.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.3    Self-injection devices

5.3.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.3.3.2   Needle-free injectors

5.3.3.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.3.3   Autoinjectors

5.3.3.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.3.4   Pen injectors

5.3.3.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.3.5   Wearable injectors

5.3.3.5.1    Market size, by region, 2018 - 2032 (USD Million)

5.3.4    Other injector devices

5.3.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.4    Topical drug delivery

5.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.2    Liquid formulations

5.4.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.4.2.2   Solutions

5.4.2.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.2.3   Suspensions

5.4.2.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.3    Semi-solid formulations

5.4.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.4.3.2   Creams

5.4.3.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.3.3   Gels

5.4.3.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.3.4   Ointments

5.4.3.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.3.5   Pastes

5.4.3.5.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.3.6   Lotions

5.4.3.6.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.4    Solid formulations

5.4.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.4.4.2   Suppositories

5.4.4.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.4.3   Powders

5.4.4.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.5    Transdermal products

5.4.5.1   Market size, by region, 2018 - 2032 (USD Million)

5.4.5.2   Transdermal patches

5.4.5.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.4.5.3   Transdermal gels

5.4.5.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.5    Ocular drug delivery

5.5.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.2    Liquid formulations

5.5.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.5.2.2   Eye drops

5.5.2.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.2.3   Liquid sprays

5.5.2.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.3    Semi-solid formulations

5.5.3.1.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.3.2   Gels

5.5.3.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.3.3   Eye ointments

5.5.3.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.4    Ocular devices

5.5.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.5.4.2   Drug-coated contact lenses

5.5.4.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.5.4.3   Ocular inserts

5.5.4.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.6    Pulmonary drug delivery

5.6.1    Market size, by region, 2018 - 2032 (USD Million)

5.6.2    Metered-dose inhalers

5.6.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.6.3    Dry powder inhalers

5.6.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.6.4    Nebulizers

5.6.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.6.4.2   Jet nebulizers

5.6.4.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.6.4.3   Ultrasonic nebulizers

5.6.4.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.6.4.4   Soft mist nebulizers

5.6.4.4.1    Market size, by region, 2018 - 2032 (USD Million)

5.7    Nasal drug delivery

5.7.1    Market size, by region, 2018 - 2032 (USD Million)

5.7.2    Nasal drops

5.7.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.7.3    Nasal sprays

5.7.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.7.4    Nasal powders

5.7.4.1   Market size, by region, 2018 - 2032 (USD Million)

5.7.5    Nasal gels

5.7.5.1   Market size, by region, 2018 - 2032 (USD Million)

5.8    Transmucosal drug delivery

5.8.1    Market size, by region, 2018 - 2032 (USD Million)

5.8.2    Oral formulations

5.8.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.8.2.2   Buccal drug delivery

5.8.2.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.8.2.3   Sublingual drug delivery

5.8.2.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.8.3    Other transmucosal drug delivery technologies

5.8.3.1   Market size, by region, 2018 - 2032 (USD Million)

5.8.3.2   Rectal drug delivery

5.8.3.2.1    Market size, by region, 2018 - 2032 (USD Million)

5.8.3.3   Vaginal drug delivery

5.8.3.3.1    Market size, by region, 2018 - 2032 (USD Million)

5.9    Implantable drug delivery

5.9.1    Market size, by region, 2018 - 2032 (USD Million)

5.9.2    Active implantable drug delivery

5.9.2.1   Market size, by region, 2018 - 2032 (USD Million)

5.9.3    Passive implantable drug delivery

5.9.3.1   Market size, by region, 2018 - 2032 (USD Million)

Chapter 6   Pharmaceutical Drug Delivery Market, By Application

6.1    Key segment trends

6.2    Infectious diseases

6.2.1    Market size, by region, 2018 - 2032 (USD Million)

6.3    Cancer

6.3.1    Market size, by region, 2018 - 2032 (USD Million)

6.4    Cardiovascular diseases

6.4.1    Market size, by region, 2018 - 2032 (USD Million)

6.5    Diabetes

6.5.1    Market size, by region, 2018 - 2032 (USD Million)

6.6    Respiratory diseases

6.6.1    Market size, by region, 2018 - 2032 (USD Million)

6.7    Central nervous system disorders

6.7.1    Market size, by region, 2018 - 2032 (USD Million)

6.8    Autoimmune diseases

6.8.1    Market size, by region, 2018 - 2032 (USD Million)

6.9    Other applications

6.9.1    Market size, by region, 2018 - 2032 (USD Million)

Chapter 7   Pharmaceutical Drug Delivery Market, By Facility of Use

7.1    Key segment trends

7.2    Hospitals

7.2.1    Market size, by region, 2018 - 2032 (USD Million)

7.3    Ambulatory surgical centers and clinics

7.3.1    Market size, by region, 2018 - 2032 (USD Million)

7.4    Home care settings

7.4.1    Market size, by region, 2018 - 2032 (USD Million)

7.5    Diagnostic centers

7.5.1    Market size, by region, 2018 - 2032 (USD Million)

7.6    Other facilities of use

7.6.1    Market size, by region, 2018 - 2032 (USD Million)

Chapter 8   Pharmaceutical Drug Delivery Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Switzerland

8.3.7    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Rest of Latin America

8.6    Middle East and Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    Rest of Middle East & Africa

Chapter 9   Company Profiles

9.1    Pfizer Inc.

9.2    Johnson & Johnson

9.3    AbbVie Inc.

9.4    Merck & Co., Inc.

9.5    Sanofi

9.6    Bayer AG

9.7    Amgen, Inc

9.8    AstraZeneca plc

9.9    Eli Lilly and Company

9.10    Gilead Science, Inc.

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

Authors: Monali Tayade, Jignesh Rawal

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore our licensing options:

Starting at: $2,450

Premium Report Details

Base Year: 2022

Companies Profiled: 10

Tables and Figures: 1673

Countries covered: 27

Pages: 850

Download Free PDF

img

Pharmaceutical Drug Delivery Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report Pharmaceutical Drug Delivery Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!